Position in VIR
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$23,113,913
+$7,820,165 QoQ
Shares Held
2,579,678
+1.7% QoQ
Ownership
1.53%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 89%
Shared 6%
None 5%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. VIR ranks #51 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in VIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,113,913 | 2,579,678 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $15,293,748 | 2,536,277 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $17,009,352 | 2,978,871 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $15,160,091 | 3,007,955 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $17,395,007 | 2,684,415 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $14,059,511 | 1,915,465 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,078,665 | 1,212,105 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $5,673,624 | 637,486 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,866,544 | 579,126 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $4,711,287 | 468,319 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $6,817,751 | 727,615 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $25,087,786 | 1,022,739 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,049,477 | 45,100 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,141,481 | 45,100 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $869,528 | 45,100 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,989,641 | 117,379 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $15,749,281 | 612,336 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $13,421,470 | 320,551 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $2,240,496 | 51,482 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,781,935 | 37,689 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,464,548 | 48,070 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $264,318 | 9,870 | Shares | Sole | 2021-03-08 | |
| 2020-09-30 | $329,430 | 9,596 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||